Source link : https://newshealth.biz/health-news/sacituzumab-before-chemo-misses-mark-in-breast-cancer-trial/
Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds. Medscape Medical News Source link : https://www.medscape.com/viewarticle/sacituzumab-before-chemo-misses-mark-breast-cancer-trial-2025a1000ypm?src=rss Author : Publish date : 2025-12-11 04:26:00 Copyright for syndicated content belongs to the linked Source.
The post Sacituzumab Before Chemo Misses Mark in Breast Cancer Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-11 04:26:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8